Transamerica Financial Advisors, LLC
Position in GILD — Gilead Sciences, Inc.
CIK 1502149
CEDAR RAPIDS, IA
Position in GILD
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$1,815,253
+$20,725 QoQ
Shares Held
14,368
+11.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#863
of 2,265 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Transamerica Financial Advisors, LLC holds $18,529,171 across 15 Drug Manufacturers - General names. GILD ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,030 | $6,033,133 | |
| 2 | MRK |
Merck & Co., Inc.
|
16,868 | $2,167,538 | |
| 3 | ABBV |
AbbVie Inc.
|
8,498 | $2,138,436 | |
| 4 | JNJ |
Johnson & Johnson
|
7,490 | $1,902,235 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
14,368 | $1,815,253 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,390 | $1,520,591 | |
| 7 | SNY |
Sanofi
|
14,570 | $621,556 | |
| 8 | AZN |
Astrazeneca PLC
|
3,264 | $618,919 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,815,253 | 14,368 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $1,794,528 | 12,876 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,574,508 | 12,828 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,442,556 | 12,996 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,403,614 | 12,660 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,463,260 | 13,059 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,400,329 | 15,160 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,412,284 | 16,845 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,171,858 | 17,080 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,251,110 | 17,080 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,974,375 | 24,372 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,283,796 | 30,475 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,509,322 | 32,559 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,647,987 | 31,915 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,666,243 | 31,057 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,079,261 | 33,705 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,892,498 | 30,618 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $653 | 11 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $798 | 11 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $768 | 11 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $757 | 11 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $710 | 11 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $640 | 11 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,011 | 16 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,936,887 | 25,174 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||